51
TITLE: Should the SELECT Trial Make Us Comfortable Using GLP-1 Receptor Agonists in HFrEF?  Full Text
AUTHORS: Neves, Joao Sergio ; Zannad, Faiez; Butler, Javed; Packer, Milton; Ferreira, Joao Pedro ;
PUBLISHED: 2024, SOURCE: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME: 84, ISSUE: 12
INDEXED IN: Scopus WOS
52
TITLE: Subclinical left ventricular dysfunction in rheumatoid arthritis: findings from the prospective Porto-RA cohort  Full Text
AUTHORS: Alexandre, Andre; Sa Couto, David; Brandao, Mariana; Cabral, Sofia; Fonseca, Tomas; Costa, Rita Quelhas; Marinho, Antonio; Vasconcelos, Carlos; Ferreira, Betania; Ferreira, Joao Pedro ; Rodrigues, Patricia;
PUBLISHED: 2024, SOURCE: CLINICAL RESEARCH IN CARDIOLOGY
INDEXED IN: Scopus WOS CrossRef
53
TITLE: The Win Ratio for Composite Outcomes in Nephrology Clinical Trials
AUTHORS: Ferreira, Joao Pedro ; Zannad, Faiez;
PUBLISHED: 2024, SOURCE: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
INDEXED IN: Scopus WOS
54
TITLE: Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSE  Full Text
AUTHORS: Ferreira, Joao Pedro ; Blatchford, Jonathan P.; Teerlink, John R.; Kosiborod, Mikhail N.; Angermann, Christiane E.; Biegus, Jan; Collins, Sean P.; Tromp, Jasper; Nassif, Michael E.; Psotka, Mitchell A.; Comin Colet, Josep; Mentz, Robert J.; Brueckmann, Martina; Nordaby, Matias; Ponikowski, Piotr; Voors, Adriaan A.;
PUBLISHED: 2024, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE
INDEXED IN: Scopus WOS
55
TITLE: Uric Acid and SGLT2 Inhibition With Empagliflozin in Heart Failure With Preserved Ejection Fraction  Full Text
AUTHORS: Doehner, Wolfram; Anker, Stefan D.; Butler, Javed; Zannad, Faiez; Filippatos, Gerasimos; Coats, Andrew J. S.; Ferreira, Joao Pedro ; Henrichmoeller, Ingrid; Brueckmann, Martina; Schueler, Elke; Pocock, Stuart J.; Januzzi, James L.; Packer, Milton;
PUBLISHED: 2024, SOURCE: JACC-HEART FAILURE, VOLUME: 12, ISSUE: 12
INDEXED IN: Scopus WOS
57
TITLE: A machine learning-derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial  Full Text
AUTHORS: Kobayashi, Masatake; Huttin, Olivier; Ferreira, Joao Pedro ; Duarte, Kevin; Gonzalez, Arantxa; Heymans, Stephane; Verdonschot, Job A. J.; Brunner La Rocca, Hans Peter; Pellicori, Pierpaolo L.; Clark, Andrew; Petutschnigg, Johannes; Edelmann, Frank G.; Cleland, John; Rossignol, Patrick; Zannad, Faiez; Girerd, Nicolas;
PUBLISHED: 2023, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 5
58
TITLE: Association between a hospitalization for heart failure and the initiation/discontinuation of guideline‐recommended treatments: An analysis from the Swedish Heart Failure Registry  Full Text
AUTHORS: Benedikt Schrage; Lars H Lund; Lina Benson; Frieder Braunschweig; João Pedro Ferreira ; Ulf Dahlström; Marco Metra; Giuseppe M.C Rosano; Gianluigi Savarese;
PUBLISHED: 2023, SOURCE: European Journal of Heart Failure, VOLUME: 25, ISSUE: 7
INDEXED IN: CrossRef: 12
59
TITLE: Blinded Withdrawal of Long-Term Randomized Treatment With Empagliflozin or Placebo in Patients With Heart Failure
AUTHORS: Packer, Milton; Butler, Javed; Zeller, Cordula; Pocock, Stuart J.; Brueckmann, Martina; Ferreira, Joao Pedro ; Filippatos, Gerasimos; Usman, Muhammad Shariq; Zannad, Faiez; Anker, Stefan D.;
PUBLISHED: 2023, SOURCE: CIRCULATION, VOLUME: 148, ISSUE: 13
INDEXED IN: WOS CrossRef: 13
60
TITLE: Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from the EMPEROR-Preserved trial  Full Text
AUTHORS: Sharma, Abhinav; Ferreira, Joao Pedro ; Zannad, Faiez; Pocock, Stuart J.; Filippatos, Gerasimos; Pfarr, Egon; Petrini, Michaela; Kraus, Bettina J.; Wanner, Christoph; Packer, Milton; Butler, Javed; Anker, Stefan D.;
PUBLISHED: 2023, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 25, ISSUE: 8
INDEXED IN: Scopus WOS CrossRef: 21
Page 6 of 39. Total results: 385.